Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

PURPOSE: Poziotinib, a pan-human epidermal growth factor receptor 2 (HER) tyrosine kinase inhibitor, has shown potent activity againstwild type of epidermal growth factorreceptor(EGFR) family kinases including EGFR, HER2, and HER4 and EGFR-mutant cells in vitro. Two phase I studies were conducted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Min, Lee, Keun-Wook, Oh, Do-Youn, Lee, Jong-Seok, Im, Seock-Ah, Kim, Dong-Wan, Han, Sae-Won, Kim, Yu Jung, Kim, Tae-You, Kim, Jee Hyun, Han, Hyesun, Kim, Woo Ho, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056959/
https://www.ncbi.nlm.nih.gov/pubmed/28859471
http://dx.doi.org/10.4143/crt.2017.303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056959/
https://www.ncbi.nlm.nih.gov/pubmed/28859471
http://dx.doi.org/10.4143/crt.2017.303

Ejemplares similares